NYSE:SYK - New York Stock Exchange, Inc. - US8636671013 - Common Stock - Currency: USD
NYSE:SYK (4/23/2025, 3:10:09 PM)
356.355
+8.24 (+2.37%)
The current stock price of SYK is 356.355 USD. In the past month the price decreased by -6.99%. In the past year, price increased by 3.73%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 27.03 | 224.09B | ||
ISRG | INTUITIVE SURGICAL INC | 65.45 | 179.13B | ||
BSX | BOSTON SCIENTIFIC CORP | 39.47 | 146.55B | ||
MDT | MEDTRONIC PLC | 15.63 | 107.03B | ||
BDX | BECTON DICKINSON AND CO | 14.47 | 57.79B | ||
EW | EDWARDS LIFESCIENCES CORP | 26.74 | 41.18B | ||
IDXX | IDEXX LABORATORIES INC | 38.11 | 34.74B | ||
RMD | RESMED INC | 24.42 | 31.70B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 14.42 | 29.65B | ||
DXCM | DEXCOM INC | 40.78 | 26.38B | ||
PHG | KONINKLIJKE PHILIPS NVR- NY | 15.34 | 22.93B | ||
STE | STERIS PLC | 24.36 | 21.97B |
Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. The company is headquartered in Portage, Michigan and currently employs 53,000 full-time employees. The firm offers products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Its segments include MedSurg and Neurotechnology and Orthopaedics. Its MedSurg products include surgical equipment, patient and caregiver safety technologies, and navigation systems (Instruments), endoscopic and communications systems (Endoscopy), and patient handling, emergency medical equipment, intensive care disposable products and clinical communication and artificial intelligence-assisted virtual care platform technology (Medical). Neurotechnology includes neurosurgical, neurovascular and craniomaxillofacial implant products. Its Orthopaedics products primarily include implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. The firm also offers solutions for venous thromboembolism clot removal without the use of thrombolytic drugs.
STRYKER CORP
1941 Stryker Way
Portage MICHIGAN 49002 US
CEO: Kevin A. Lobo
Employees: 53000
Company Website: https://www.stryker.com/
Investor Relations: https://investors.stryker.com
Phone: 12693852600
The current stock price of SYK is 356.355 USD. The price increased by 2.37% in the last trading session.
The exchange symbol of STRYKER CORP is SYK and it is listed on the New York Stock Exchange, Inc. exchange.
SYK stock is listed on the New York Stock Exchange, Inc. exchange.
37 analysts have analysed SYK and the average price target is 437.44 USD. This implies a price increase of 22.75% is expected in the next year compared to the current price of 356.355. Check the STRYKER CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
STRYKER CORP (SYK) has a market capitalization of 136.02B USD. This makes SYK a Large Cap stock.
STRYKER CORP (SYK) currently has 53000 employees.
STRYKER CORP (SYK) has a support level at 348.01 and a resistance level at 349.23. Check the full technical report for a detailed analysis of SYK support and resistance levels.
The Revenue of STRYKER CORP (SYK) is expected to grow by 8.85% in the next year. Check the estimates tab for more information on the SYK EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
STRYKER CORP (SYK) has a dividend yield of 0.97%. The yearly dividend amount is currently 3.2. Check the full fundamental report for a detailed analysis of SYK dividend history, reliability and sustainability.
STRYKER CORP (SYK) will report earnings on 2025-05-01, after the market close.
The PE ratio for STRYKER CORP (SYK) is 29.23. This is based on the reported non-GAAP earnings per share of 12.19 and the current share price of 356.355 USD. Check the full fundamental report for a full analysis of the valuation metrics for SYK.
The outstanding short interest for STRYKER CORP (SYK) is 1.32% of its float. Check the ownership tab for more information on the SYK short interest.
ChartMill assigns a technical rating of 1 / 10 to SYK. When comparing the yearly performance of all stocks, SYK turns out to be only a medium performer in the overall market: it outperformed 53.78% of all stocks.
ChartMill assigns a fundamental rating of 6 / 10 to SYK. SYK scores excellent on profitability, but there are some minor concerns on its financial health.
Over the last trailing twelve months SYK reported a non-GAAP Earnings per Share(EPS) of 12.19. The EPS increased by 15% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 13.25% | ||
ROA | 6.97% | ||
ROE | 14.51% | ||
Debt/Equity | 0.59 |
ChartMill assigns a Buy % Consensus number of 80% to SYK. The Buy consensus is the average rating of analysts ratings from 37 analysts.
For the next year, analysts expect an EPS growth of 10.69% and a revenue growth 8.85% for SYK